Alterations in CDKN2A and CDKN2B, such as mutations or deletions, are common in RCC and are linked to poor survival across multiple histologies, including clear cell, papillary, collecting duct, and chromophobe RCC [63,174]. Here, CDKN2A is linked to renal cell carcinoma.